Ellevest, Inc. Bristol Myers Squibb CO Transaction History

Ellevest, Inc.

$1.48 Billion
Q1 2025

A detailed history of Ellevest, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ellevest, Inc. holds 6,443 shares of BMY stock, worth $309,843. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,443

Previous 10,394 38.01%

Holding current value

$309,843

Previous $587,000 33.22%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$53.9 - $63.11 $212,958 - $249,347	-3,951 Reduced 38.01%	6,443 $392,000
Q4 2024 Feb 14, 2025	BUY	$51.92 - $59.94 $86,031 - $99,320	1,657 Added 18.97%	10,394 $587,000
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $5,671 - $7,400	-143 Reduced 1.61%	8,737 $452,000
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $7,486 - $9,856	186 Added 2.14%	8,880 $368,000
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $4,126 - $4,678	86 Added 1.0%	8,694 $471,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $56,430 - $67,337	-1,164 Reduced 11.91%	8,608 $441,000
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $17,598 - $19,677	-304 Reduced 3.02%	9,772 $567,000
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $40,392 - $44,849	634 Added 6.71%	10,076 $644,000
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $218,945 - $248,333	-3,332 Reduced 26.08%	9,442 $654,000
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $73,821 - $87,415	1,078 Added 9.22%	12,774 $918,000
Q3 2022 Nov 02, 2022	BUY	$0.13 - $76.84 $63 - $37,805	492 Added 4.39%	11,696 $831,000
Q2 2022 Jul 18, 2022	BUY	$72.62 - $79.98 $83,730 - $92,216	1,153 Added 11.47%	11,204 $863,000
Q1 2022 Apr 19, 2022	BUY	$61.48 - $73.72 $158,003 - $189,460	2,570 Added 34.35%	10,051 $734,000
Q4 2021 Jan 24, 2022	BUY	$53.63 - $62.52 $252,436 - $294,281	4,707 Added 169.68%	7,481 $466,000
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $10,058 - $11,782	170 Added 6.53%	2,774 $164,000
Q2 2021 Jul 13, 2021	BUY	$61.91 - $67.42 $22,659 - $24,675	366 Added 16.35%	2,604 $174,000
Q1 2021 May 03, 2021	SELL	$59.34 - $66.74 $10,562 - $11,879	-178 Reduced 7.37%	2,238 $141,000
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $16,686 - $18,909	289 Added 13.59%	2,416 $150,000
Q3 2020 Oct 26, 2020	BUY	$57.43 - $63.64 $4,594 - $5,091	80 Added 3.91%	2,127 $128,000
Q2 2020 Jul 06, 2020	BUY	$54.82 - $64.09 $27,410 - $32,045	500 Added 32.32%	2,047 $120,000
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $1,392 - $2,022	-30 Reduced 1.9%	1,547 $86,000
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $66,679 - $86,977	1,355 Added 610.36%	1,577 $101,000
Q3 2019 Oct 08, 2019	SELL	$42.77 - $50.71 $39,091 - $46,348	-914 Reduced 80.46%	222 $11,000
Q2 2019 Aug 20, 2019	BUY	$44.62 - $49.34 $50,688 - $56,050	1,136 New	1,136 $52,000

Others Institutions Holding BMY

# of Institutions

2,810

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $102B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account